The main risk is not technological obsolescence but monetization timing. ASML can have strong underlying demand and still miss the bullish equity case if export controls cut China, Zeiss or other bottlenecks constrain output, or customers delay
fab readiness and next-generation
EUV insertion. Because the stock already carries a premium scarcity valuation, modest operating slippage can matter more to returns than to franchise value.